Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

11069	Companies
242900	Keywords
171086	Articles
130755	Press releases

Home
Companies
Biophytis

PRESS RELEASE

published on 01/04/2024 at 07:00, 2 years 8 months ago

Biophytis announces the publication of the results of its COVA phase 2-3 study in eClinicalMedicine, part of The Lancet
Biophytis announces the publication of the results of its COVA phase 2-3 study in eClinicalMedicine, part of The Lancet. The publication highlights the positive results of Sarconeos (BIO101) in reducing the risk of death or respiratory failure in adults hospitalized with severe respiratory symptoms due to COVID-19. Biophytis will also host press conferences to discuss the potential and clinical benefits of Sarconeos (BIO101) in severe forms of COVID-19 and its exploration in the treatment of other respiratory viral infections. For more information, visit www.biophytis.com

Biophytis COVA Phase 2-3 Study Sarconeos (BIO101) Publication Severe COVID-19 Treatment Respiratory Viral Infections Clinical Benefits Of Sarconeos (BIO101)
ARTICLE

published on 12/29/2023 at 07:59, 2 years 8 months ago

Biophytis avance dans son financement avec l'émission de la quatrième tranche d'ORNANE
Biophytis annonce le tirage de la quatrième tranche d'ORNANE auprès du fonds d’investissement Atlas sous le cadre du contrat de financement conclu en 2021

Biophytis Financement ORNANE Atlas Médicament
PRESS RELEASE

published on 12/29/2023 at 07:00, 2 years 8 months ago

Biophytis annonce le tirage de la quatrième tranche d'ORNANE dans le cadre du contrat Atlas 2021
Biophytis annonce le tirage de la quatrième tranche d'ORNANE dans le cadre du contrat Atlas 2021. La société de biotechnologie au stade clinique spécialisée dans le développement de traitements qui visent à ralentir les processus dégénératifs liés au vieillissement va émettre 80 ORNANE pour un montant de 2 millions d’euros, avec une option complémentaire de 80 ORNANE pour un montant de 2 millions d’euros le 15 février 2024

Biophytis ORNANE Atlas 2021 Fonds D'investissement Obligations Remboursables
PRESS RELEASE

published on 12/29/2023 at 07:00, 2 years 8 months ago

Biophytis announces the drawing of the fourth tranche of ORNANE under the 2021 Atlas Contract
Biophytis, a clinical-stage biotechnology company focused on developing therapeutics for age-related diseases, has announced the drawing of the fourth tranche of its convertible bond agreement with Atlas, a specialized investment fund based in New York. This tranche consists of 80 Bonds Redeemable in Cash and New and Existing Shares (ORNANE) with a total value of €4 million. The ORNANE have a 24-month maturity period and do not bear interest. Holders have the option
ARTICLE

published on 12/11/2023 at 07:49, 2 years 9 months ago

Biophytis présente son calendrier de conférences internationales pour le premier trimestre 2024
Biophytis SA confirme sa présence dans des conférences clés du secteur de la santé, visant à renforcer ses relations et à présenter ses avancées

Biophytis Biotechnologie Sarconeos (BIO101) Conférences Traitements Anti-vieillissement
ARTICLE

published on 12/04/2023 at 08:00, 2 years 9 months ago

Biophytis et l'Université de Liège s'associent pour combattre l'insuffisance respiratoire virale
Biophytis annonce un partenariat avec l'Université de Liège pour étudier Sarconeos (BIO101) dans le traitement de pathologies respiratoires

Biophytis Université De Liège Insuffisance Respiratoire Recherche Préclinique Médicament Sarconeos
PRESS RELEASE

published on 11/27/2023 at 07:00, 2 years 9 months ago

Biophytis nomme Yann Meunier et Bernard Lévy à son comité scientifique
PRESS RELEASE

published on 11/20/2023 at 07:00, 2 years 10 months ago

Biophytis annonce le succès de son augmentation de capital avec maintien du droit préférentiel de souscription pour un montant d’environ 1,96 M€
PRESS RELEASE

published on 11/17/2023 at 23:00, 2 years 10 months ago

Biophytis reçoit une notification du Nasdaq
PRESS RELEASE

published on 11/06/2023 at 07:00, 2 years 10 months ago

Biophytis to attend BIO-Europe in Munich

Accesswire

Published on 09/24/2026 at 13:00, 15 minutes ago

NOA Lithium Provides Update on 2026 Exploration Campaign and Provides Corporate Updates
Published on 09/24/2026 at 13:00, 15 minutes ago

Kalo Gold's Wainikoro Corridor Extends 4.3 Kilometres and Remains Open, with Gold Results to 8.78 g/t Au Along its Length, Vatu Aurum, Fiji
Published on 09/24/2026 at 13:00, 15 minutes ago

Prospect Ridge Stakes Additional Targets at Excalibur Following Successful Initial Drill Program
Published on 09/24/2026 at 12:58, 17 minutes ago

BlackBerry Reports Second Quarter Fiscal Year 2027 Results
Published on 09/24/2026 at 11:00, 2 hours 15 minutes ago

Silver Range Defines Targets at the Drum Property in Utah

View all ACCESSWIRE

EQS Group

Published on 09/24/2026 at 12:40, 34 minutes ago

Driving Global Growth: FAW TRUCKS Chairman on European Expansion, Capital Discipline and TCO Strategy
Published on 09/24/2026 at 12:35, 39 minutes ago

Hitachi Solutions achieves the 2026-2027 Microsoft AI Business Solutions Inner Circle award.
Published on 09/24/2026 at 12:35, 39 minutes ago

Bybit Unveils "Make Your Move" as New Global Brand Campaign for The New Financial Platform
Published on 09/24/2026 at 12:34, 40 minutes ago

Change in Management at secunet: Dr Alexandra Heine succeeds Jessica Nospers as CFO
Published on 09/24/2026 at 12:28, 47 minutes ago

FamiCord AG wins promising new client for its CDMO activities with manufacturing agreement for pivotal Phase II/III trial with initial value in the low single-digit millions of euros

Les Echos

Published on 09/24/2026 at 08:00, 5 hours 15 minutes ago

Neoen launches construction of 3 solar farms and a wind farm in France, with a total capacity of 101 MW
Published on 09/24/2026 at 08:00, 5 hours 15 minutes ago

Neoen lance la construction de trois parcs solaires et un parc éolien en France pour une capacité totale de 101 MW
Published on 09/24/2026 at 07:30, 5 hours 45 minutes ago

Gimv rondt met succes private plaatsing van een obligatie af voor een bedrag van EUR 150 miljoen
Published on 09/24/2026 at 07:30, 5 hours 45 minutes ago

Gimv successfully completes private placement of a bond for an amount of EUR 150 million
Published on 09/24/2026 at 07:30, 5 hours 45 minutes ago

Gimv successfully completes private placement of a bond for an amount of EUR 150 million

View all LES ECHOS COMFI WIRE